Document is current
Any future updates will be listed below
-
Authors
Trudzinski, Franziska C. http://orcid.org/0000-0002-0980-7586
Michels-Zetsche, Julia D.
Neetz, Benjamin
Meis, Jan
Müller, Michael
Kempa, Axel
Neurohr, Claus
Schneider, Armin
Herth, Felix J. F.
Szecsenyi, Joachim
Biehler, Elena
Fleischauer, Thomas
Wensing, Michel
Britsch, Simone
Schubert-Haack, Janina
Grobe, Thomas
Frerk, Timm
,
Herth, Felix
Iberl, Gabriele
Michels, Julia Dorothea
Müller, Beatrice
Müller, Michael
Neetz, Benjamin
Trudzinski, Franziska Christina
Bentner, Martina
Biehler, Elena
Fleischhhauer, Thomas
Forstner, Johanna
Fuchs, Gerhard
Litke, Nicola
Qreini, Markus
von Schumann, Selina
Sturm, Noemi
Szecsenyi, Joachim
Weis, Aline
Wensing, Michel
Frerk, Timm
Grobe, Thomas
Schubert-Haack, Janina
Klingenberg, Anja
Meis, Jan
Kempa, Alex
Joves, Biljana
Rheinhold, Andreas
Ehab, Ahmed
Neurohr, Claus
Ghiani, Alessandro
Lutz, Nina
Walcher, Swenja
Tsitouras, Konstantinos
Paderewska, Joanna
Briese, Selina
Schneider, Armin
Rauch, Christoph
Gehrig, Patrick
Sugg, Joachim
Hirschmann, Susanne
Britsch, Simone
Straub, Christa
Jabbour, Claude
Hahn, Michael
Krebs, Jörg
Graf, Peter-Tobias
Denzer, Petra
Merle, Uta
Fiedler, Mascha
Hundt, Guido
Regula, Jens
Bomeken, Miriane
Stier, Sebastian
Müller, Jens
Oltmanns, Ute
Terboven, Tom
Hennersdorf, Marcus
Satir, Neslihan
Borst, Mathias
Mayer, Brigitte
Reikow, Wolfgang
Kredel, Markus
Keppeler, Patrick
Frey, Konstantin
Wolff, Holger
Seidlitz, Florian
Bientzle, Stefanie
Nohé, Boris
Allgäuer, Sebastian
Schöpp, Alexej
Schlegel, Christoph
Hübner, Imke
Kuzniar, Andrezj
Häberle, Helene
Riessen, Reimer
Schempf, Benjamin
Rebenschütz, Ingo
Straub, Andreas
Kollum, Marc
Winter, Markus
Hartveg, Paul
Junginger, Andreas
Beck, Helmut
Vogel, Mathias
Völker, Ralf
Wiesmann, Thomas
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05260853 at ClinicalTrials.govDocuments that mention this clinical trial
Risk factors for long-term invasive mechanical ventilation: a longitudinal study using German health claims data
https://doi.org/10.1186/s12931-024-02693-6
-
Funding
Funding for this research was provided by:
Innovation Fund of the Federal Joint Committee (01NVF19023)
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 5 September 2023
Accepted: 18 January 2024
First Online: 27 January 2024
Declarations
:
: The study protocol version 1.0 was first approved by the ethics committee of the Medical Faculty Heidelberg prior to the start of the study (S-352/2018) on 18th September 2020, version 1.4. was approved on 27th April 2021. Data protection is guaranteed in accordance with the European Data Protection Regulation, the Baden-Württemberg State Data Protection Act, and the Federal Data Protection Act. Furthermore, the data protection concept has been reviewed and accepted by the data protection officer of the Heidelberg University Hospital. In accordance with the data protection regulations and the ethics vote, written patient consent was not considered necessary in this contex.
: In addition to the stated funding from the Innovation Fund of the Federal Joint Committee (G-BA), FCT reports payment or honoraria for lectures, or reimbursement of travel expenses from Novartis AG, GlaxoSmithKline, Chiesi, Boehringer Ingelheim Gmbh, Grifols and AstraZeneca. JS holds stocks of the aQua Institute for Applied Quality Improvement and Research in Health Care. JDM, BN, JM, MM, AK, CN, AS, FJFH, EB, TF, MW, SB, JSH, TB and TF have no competing interests.
